ALPHA.1-PROTEINASE INHIBITOR HUMAN for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where ALPHA.1-PROTEINASE INHIBITOR HUMAN was used for Immunodeficiency common variable.
Most Reported Side Effects for ALPHA.1-PROTEINASE INHIBITOR HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 1,011 | 14.2% | 57 | 440 |
| Pneumonia | 681 | 9.6% | 71 | 487 |
| Fatigue | 669 | 9.4% | 22 | 121 |
| Headache | 631 | 8.9% | 8 | 95 |
| Death | 456 | 6.4% | 454 | 108 |
| Cough | 447 | 6.3% | 12 | 168 |
| Product dose omission issue | 397 | 5.6% | 45 | 203 |
| Nausea | 385 | 5.4% | 14 | 90 |
| Malaise | 367 | 5.2% | 16 | 120 |
| Dizziness | 314 | 4.4% | 5 | 63 |
| Pain | 287 | 4.0% | 15 | 96 |
| Pyrexia | 270 | 3.8% | 11 | 103 |
| Covid-19 | 255 | 3.6% | 20 | 155 |
| Fall | 248 | 3.5% | 30 | 140 |
| Nasopharyngitis | 243 | 3.4% | 8 | 76 |
Other Indications for ALPHA.1-PROTEINASE INHIBITOR HUMAN
Alpha-1 antitrypsin deficiency (2,984)
Alpha-1 anti-trypsin deficiency (2,937)
Product used for unknown indication (591)
Emphysema (240)
Chronic obstructive pulmonary disease (141)
Obstructive airways disorder (39)
Asthma (34)
Graft versus host disease (26)
Immune system disorder (24)
Supplementation therapy (24)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
GAMMAGARD LIQUID (81)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)